Does Anthem Cover Wegovy? Insurance Guide 2026

Weight loss and diabetes management have evolved significantly with the introduction of groundbreaking medications like Wegovy. As a glucagon-like peptide-1 (GLP-1) receptor agonist, Wegovy has shown remarkable efficacy in promoting sustainable weight loss and improving glycemic control. For millions of Anthem insurance members, understanding whether their plan covers Wegovy is crucial for accessing this transformative treatment. This comprehensive guide explores Anthem’s coverage policies for Wegovy in 2026, including eligibility criteria, cost considerations, and steps to secure approval or appeal denials.

Does Anthem Cover Wegovy for Diabetes?

Anthem’s coverage of Wegovy for diabetes management depends on the specific plan and medical necessity. Wegovy, which contains semaglutide, is FDA-approved for chronic weight management but is also prescribed off-label for type 2 diabetes due to its glucose-lowering effects. Anthem typically aligns its coverage policies with FDA indications and clinical guidelines, meaning Wegovy may be covered for diabetes if the patient meets certain criteria.

To qualify, members usually need a documented diagnosis of type 2 diabetes with inadequate glycemic control despite lifestyle modifications and other diabetes medications. Anthem may require prior authorization, demonstrating that Wegovy is medically necessary and that other treatments (e.g., metformin, SGLT2 inhibitors) have failed or are contraindicated. Additionally, Anthem may consider covering Wegovy for diabetes if the patient has obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with weight-related comorbidities, as these conditions often exacerbate insulin resistance.

Anthem’s coverage decisions are also influenced by clinical evidence supporting Wegovy’s benefits in reducing HbA1c levels and improving cardiovascular outcomes in diabetic patients. However, coverage varies by state and plan type (e.g., employer-sponsored, Medicare Advantage, or Medicaid). Members should review their plan’s formulary or contact Anthem directly to confirm whether Wegovy is included for diabetes management.

Does Anthem Cover Wegovy for Weight Loss?

Anthem’s coverage of Wegovy for weight loss is more straightforward, as the medication is FDA-approved for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related condition, such as hypertension or dyslipidemia. Anthem generally covers Wegovy for weight loss if the member meets these criteria and obtains prior authorization.

To qualify, patients must provide evidence of a documented weight loss attempt through lifestyle interventions (e.g., diet, exercise) for at least six months without sufficient results. Anthem may also require a prescription from a healthcare provider, along with proof of ongoing participation in a structured weight management program. Some plans may limit Wegovy coverage to a specific duration (e.g., 12–24 months) or require step therapy, where patients must try less expensive weight loss medications first.

Anthem’s coverage policies for Wegovy are designed to ensure cost-effective use while prioritizing patients with the greatest medical need. However, coverage details can vary by plan, so members should verify their benefits or consult Anthem’s customer service. For those without coverage, Anthem may offer alternatives like Saxenda (liraglutide) or Zepbound (tirzepatide), which are also approved for weight loss.

How Much Does Wegovy Cost With Anthem?

The out-of-pocket cost of Wegovy with Anthem insurance depends on the plan’s formulary tier, copay structure, and deductible. Without insurance, Wegovy can cost upwards of $1,300–$1,600 per month, making insurance coverage essential for most patients. With Anthem, the cost typically ranges from $25 to $500 per month, depending on whether the medication is classified as a preferred or non-preferred drug.

For members with a standard Anthem plan, Wegovy is often placed on Tier 3 or Tier 4 of the formulary, which may require a higher copay or coinsurance (e.g., 30–50% of the drug’s cost). Some plans may cover Wegovy at a lower tier if the patient meets specific clinical criteria, such as a BMI ≥ 40 or a history of weight-related complications. Anthem’s Medicare Advantage and Medicaid plans may have different cost-sharing structures, so members should review their Evidence of Coverage (EOC) document for details.

To reduce costs, patients can explore Anthem’s preferred pharmacy network, which may offer lower copays for Wegovy. Additionally, Novo Nordisk, the manufacturer of Wegovy, provides a savings card that can lower out-of-pocket expenses to as little as $0–$25 per month for eligible commercially insured patients. However, savings programs may not apply to Medicare or Medicaid beneficiaries. Members should also inquire about mail-order pharmacy options, which can sometimes offer discounts on Wegovy.

Wegovy Prior Authorization for Anthem

Anthem requires prior authorization for Wegovy to ensure the medication is prescribed appropriately and cost-effectively. The prior authorization process involves the healthcare provider submitting clinical documentation to justify the need for Wegovy, including the patient’s BMI, weight-related comorbidities, and history of failed weight loss attempts with lifestyle modifications.

For Wegovy approval, Anthem typically requires the following:

1. BMI Documentation: Proof of obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related condition (e.g., hypertension, type 2 diabetes).
2. Medical History: Evidence of prior weight loss attempts, such as participation in a structured diet or exercise program for at least six months.
3. Provider Attestation: A statement from the prescribing physician confirming that Wegovy is medically necessary and that other treatments have been ineffective.
4. Lab Results: For diabetic patients, recent HbA1c levels may be required to demonstrate inadequate glycemic control.

Anthem reviews prior authorization requests within 3–14 days, depending on the urgency. If approved, coverage is typically granted for 6–12 months, after which reauthorization may be required. If denied, the provider can appeal the decision by submitting additional clinical evidence or requesting a peer-to-peer review with an Anthem medical director. Patients should work closely with their healthcare team to ensure all required documentation is submitted accurately to avoid delays.

How to Get Anthem to Cover Wegovy

Securing Anthem coverage for Wegovy requires a strategic approach, starting with a thorough understanding of the plan’s requirements. Here’s a step-by-step guide to improving the chances of approval:

1. Confirm Eligibility: Ensure the patient meets Anthem’s criteria for Wegovy coverage, such as a BMI ≥ 30 or BMI ≥ 27 with weight-related comorbidities. For diabetes, document inadequate glycemic control despite other treatments.
2. Gather Documentation: Collect medical records, including BMI measurements, lab results (e.g., HbA1c for diabetics), and evidence of prior weight loss attempts (e.g., dietitian notes, exercise logs).
3. Obtain a Prescription: Have a healthcare provider prescribe Wegovy and include a detailed letter of medical necessity outlining why the patient requires this specific medication.
4. Submit Prior Authorization: The provider’s office should submit the prior authorization request to Anthem, including all supporting documentation. Anthem’s online portal or fax can be used for submission.
5. Follow Up: Track the status of the prior authorization request and respond promptly to any requests for additional information from Anthem.
6. Explore Appeals: If denied, request a formal appeal. The provider can submit a letter of appeal with additional clinical evidence or request a peer-to-peer review with an Anthem medical director.
7. Utilize Savings Programs: If coverage is limited, apply for Novo Nordisk’s Wegovy savings card, which can reduce out-of-pocket costs for eligible patients.

Patients should also consider consulting an Anthem case manager or a patient advocacy group for assistance navigating the coverage process.

What to Do If Anthem Denies Wegovy

If Anthem denies coverage for Wegovy, patients have several options to challenge the decision and potentially secure approval. The first step is to understand the reason for denial, which is typically outlined in Anthem’s Explanation of Benefits (EOB) or denial letter. Common reasons include insufficient documentation, failure to meet BMI criteria, or lack of prior weight loss attempts.

To appeal the denial:

1. Request a Reconsideration: The prescribing physician can submit a letter of appeal to Anthem, providing additional clinical evidence or clarifying any missing information. This may include updated lab results, a more detailed medical history, or proof of participation in a weight management program.
2. Peer-to-Peer Review: The provider can request a discussion with an Anthem medical director to review the case and explain why Wegovy is medically necessary.
3. External Review: If the internal appeal is unsuccessful, patients can request an external review by an independent third party. This process is available for fully insured plans and may overturn Anthem’s decision if the denial is deemed unreasonable.
4. Legal or Advocacy Support: Patients can seek assistance from patient advocacy organizations or legal aid services specializing in insurance appeals. These groups can provide guidance on navigating the appeals process and may intervene on the patient’s behalf.

If all appeals fail, patients can explore alternative weight loss medications covered by Anthem, such as Saxenda or Zepbound, or discuss self-pay options with their provider. Novo Nordisk’s savings program may also help reduce the cost of Wegovy for those without insurance coverage.

Anthem Alternatives If Wegovy Is Not Covered

If Anthem does not cover Wegovy, patients have several alternatives to explore for weight loss or diabetes management. Anthem’s formulary may include other GLP-1 receptor agonists or weight loss medications that are more accessible or cost-effective.

1. Saxenda (Liraglutide): Like Wegovy, Saxenda is a GLP-1 receptor agonist approved for chronic weight management. It is often covered by Anthem and may be a suitable alternative for patients who cannot access Wegovy. Saxenda is administered daily via injection, whereas Wegovy is a weekly injection.
2. Zepbound (Tirzepatide): Approved for weight loss in 2023, Zepbound is a dual GLP-1 and GIP receptor agonist that has shown superior weight loss results compared to Wegovy in clinical trials. Anthem may cover Zepbound for patients who meet specific criteria, such as a BMI ≥ 30 or BMI ≥ 27 with comorbidities.
3. Contrave (Naltrexone/Bupropion): This oral medication combines two drugs to reduce appetite and cravings. It is often covered by Anthem and may be a more affordable option for weight loss.
4. Qsymia (Phentermine/Topiramate): Another oral weight loss medication, Qsymia is approved for chronic weight management and may be covered by Anthem. It is typically prescribed for patients with a BMI ≥ 30 or BMI ≥ 27 with weight-related conditions.
5. Lifestyle Interventions: Anthem may cover weight loss programs, such as Nutrisystem or Weight Watchers, as part of its wellness benefits. These programs can be combined with medication for better results.

Patients should consult their healthcare provider to determine the best alternative to Wegovy based on their medical history, insurance coverage, and treatment goals. Additionally, Anthem’s customer service can provide a list of covered weight loss medications and programs.

Frequently Asked Questions

Does Anthem cover Wegovy for weight loss?

Yes, Anthem typically covers Wegovy for weight loss if the patient meets FDA-approved criteria, such as a BMI ≥ 30 or BMI ≥ 27 with weight-related comorbidities. Prior authorization is usually required, and coverage may vary by plan.

How much is the Wegovy copay with Anthem?

The Wegovy copay with Anthem ranges from $25 to $500 per month, depending on the plan’s formulary tier and cost-sharing structure. Patients can reduce costs by using Novo Nordisk’s savings card or Anthem’s preferred pharmacy network.

Can I appeal if Anthem denies Wegovy?

Yes, patients can appeal an Anthem denial for Wegovy by submitting additional clinical evidence, requesting a peer-to-peer review, or pursuing an external review. Legal or advocacy support may also help strengthen the appeal.

Disclaimer from HealthLeague Medical Board: This article is for informational purposes only and does not constitute medical or insurance advice. Coverage policies for Wegovy may change, and individual plan details vary. Always consult your Anthem plan documents, healthcare provider, or Anthem customer service for the most accurate and up-to-date information regarding your coverage.